MoHAP boosts medical, pharma manufacturing

DUBAI — The Ministry of Health and Prevention (MoHAP) revealed that that the number of licenced health and pharmaceutical facilities has surged to 3,410, while the total number of workers in the public and private health sectors is 26,931.

Local medical industries, including medicine, medical equipment, and supplies, have also made a qualitative jump in terms of enhancing quality and competitiveness, thanks to the UAE’s ideal investment environment, flexible legislations, the leading infrastructure and technology, intellectual property laws, and the reliance on artificial intelligence in the manufacturing of medical products.

Dr Amin Hussein Al Amiri, assistant under-secretary of the ministry’s public health policy and licenses, referred to Mo

Hap’s cooperation with a working group to review the national medical industries, based on the Cabinet decisions, pointing to the ongoing work to shape postCovid-19 policy, update pharmacovigilance and national drug policies to cope with global developments.

“Enhancing pharmaceutical and medical security is a strategic priority for the ministry to handle any emergency circumstances that may lead to disruption in supply chains. To that end, the ministry is keen to provide an attractive and competitive legislative and investment environment with the best facilities and privileges, expertise and research capabilities, and several initiatives and incentives that would help establish competitive medical industries, thus paving the way for many international companies to set up their plants and their R&D centres in the UAE,” Dr Al Amiri said.

“The number of licenced local factories has risen to 19 factories [with four under registration], in addition to 13 that will be registered in the upcoming years. There are also 83 scientific or marketing offices for international pharmaceutical companies.” —